Centiva Capital LP Has $275,000 Stock Position in Hawkins, Inc. (NASDAQ:HWKN)

Centiva Capital LP lowered its position in Hawkins, Inc. (NASDAQ:HWKN) by 33.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,158 shares of the specialty chemicals company’s stock after selling 1,098 shares during the period. Centiva Capital LP’s holdings in Hawkins were worth $275,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. EFG Asset Management North America Corp. acquired a new stake in Hawkins in the 2nd quarter valued at $1,507,000. Aptus Capital Advisors LLC bought a new stake in shares of Hawkins during the second quarter worth about $4,741,000. State of New Jersey Common Pension Fund D acquired a new stake in shares of Hawkins in the 3rd quarter worth about $2,021,000. Bridges Investment Management Inc. bought a new position in Hawkins in the 2nd quarter valued at about $487,000. Finally, Public Sector Pension Investment Board boosted its stake in Hawkins by 6.6% during the 2nd quarter. Public Sector Pension Investment Board now owns 41,857 shares of the specialty chemicals company’s stock valued at $3,809,000 after purchasing an additional 2,599 shares during the last quarter. Institutional investors and hedge funds own 69.71% of the company’s stock.

Hawkins Price Performance

Shares of NASDAQ:HWKN opened at $137.01 on Thursday. The company has a current ratio of 2.27, a quick ratio of 1.39 and a debt-to-equity ratio of 0.21. The stock has a market cap of $2.87 billion, a PE ratio of 35.04, a price-to-earnings-growth ratio of 4.69 and a beta of 0.83. The stock’s fifty day simple moving average is $126.47 and its two-hundred day simple moving average is $113.57. Hawkins, Inc. has a 1-year low of $54.44 and a 1-year high of $139.55.

Hawkins (NASDAQ:HWKN) last released its quarterly earnings results on Wednesday, October 30th. The specialty chemicals company reported $1.16 earnings per share for the quarter, missing analysts’ consensus estimates of $1.18 by ($0.02). Hawkins had a net margin of 8.74% and a return on equity of 19.64%. The firm had revenue of $247.03 million for the quarter, compared to the consensus estimate of $259.59 million. As a group, analysts forecast that Hawkins, Inc. will post 4.12 EPS for the current fiscal year.

Hawkins Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were paid a $0.18 dividend. The ex-dividend date was Friday, November 15th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.53%. Hawkins’s payout ratio is presently 18.41%.

Wall Street Analyst Weigh In

Separately, BWS Financial reissued a “neutral” rating and issued a $122.00 price objective on shares of Hawkins in a research note on Thursday, October 31st.

Hawkins Company Profile

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.